Anti-edematous effect of escin lysinate in patients treated with corrective foot osteotomy
https://doi.org/10.18019/1028-4427-2026-32-3-371-379
Abstract
Introduction Surgical treatment of the forefoot deformities using corrective osteotomies can be associated with local reactions, manifested by postoperative swelling and pain. The factors can impact the timing and quality of early patient rehabilitation. The search for safe and effective means to relieve postoperative swelling and pain is essential in modern traumatology and orthopedics. The escin lysinate solution with angioprotective, anti-edematous, and analgesic effects, is considered as a pathogenetically substantiated approach.
The objective was to compare the efficacy and safety of escin lysinate used to reduce postoperative swelling and pain in patients after corrective osteotomies of the foot and the standard therapy and therapy supplemented with a short course of systemic glucocorticosteroids.
Material and methods A prospective randomized study included 30 patients (18–70 years) who underwent SCARF osteotomy of the first metatarsal bone, AKIN osteotomy, and/or Weil osteotomy. Patients were divided into three groups (10 individuals each) who underwent standard therapy (control); standard therapy + escin lysinate; standard therapy + dexamethasone. The severity of swelling of the limb, pain assessed with the visual analog scale (VAS), the need for nonsteroidal anti-inflammatory drugs (NSAIDs), the level of C-reactive protein, and the safety of therapy were dynamically evaluated.
Results The pain significantly reduced in the first three postoperative days in the escin lysinate group as compared to the control group with a reduced need for NSAIDs. A greater edema regression was observed at the metatarsal level at six weeks. Dynamics in pain was noted in the dexamethasone group at a short term with a less need for NSAIDs. No adverse reactions or clinically significant changes in laboratory parameters were recorded.
Discussion Postoperative edema was more evident in the foot as compared to other anatomical sites due to limited soft tissue volume and slow venous and lymphatic outflow from the distal extremities. In this context, medications that reduce vascular and tissue permeability play a role. Aescin lysinate was shown to demonstrate efficacy in neurosurgery and otolaryngology with the use being associated with reduceed edema and inflammation. In orthopedics and traumatology, the drug demonstrated angioprotective and analgesic potential in lower extremity injuries. Unlike systemic glucocorticosteroids such as dexamethasone having a pronounced but short-term anti-inflammatory effect and being associated with the risk of hyperglycemia, infections and bone loss, escin lysinate has a safety profile and can be considered as a pathogenetically justified agent for the control of postoperative inflammation and edema.
Conclusion A comparative evaluation of the adjuvant use of escin lysinate, standard therapy, and therapy supplemented with a short course of systemic glucocorticosteroids after corrective foot osteotomies demonstrated earlier pain relief and accelerated edema resolution with no risk of adverse reactions with escin lysinate. The drug can be considered an effective and safe addition to standard therapy, providing a more favorable early postoperative effect.
About the Authors
E. V. WeberRussian Federation
Evgeny V. Weber — Candidate of Medical Sciences, Head of the Department, Head of the Division, Associate Professor
St. Petersburg
S. S. Smirnov
Russian Federation
Sergey S. Smirnov — Head of the Department, Orthopaedic Surgeon
St. Petersburg
Sh. L. Shaylieva
Russian Federation
Sheridan L. Shaylieva — Resident Physician
St. Petersburg
M. A. Zhogina
Russian Federation
Margarita A. Zhogina — Laboratory Assistant, Orthopaedic Surgeon
St. Petersburg
A. R. Kasimova
Russian Federation
Alina R. Kasimova — Candidate of Medical Sciences, Associate Professor, Associate Professor of the Department, Clinical Pharmacologist
St. Petersburg
S. A. Bozhkova
Russian Federation
Svetlana A. Bozhkova — Doctor of Medical Sciences, Professor, Head of the Department
St. Petersburg
References
1. Скребцов А.В., Никитина В.К., Процко В.Г. и др. Анализ среднесрочных результатов коррекции вальгусной деформации первого пальца стопы. Вестник травматологии и ортопедии им. Н.Н. Приорова. 2023;30(3): 315-324. doi: 10.17816/vto430259.
2. Олейник А.В., Беленький И.Г., Сергеев Г.Д. и др. Оригинальный направитель для малоинвазивной дистальной остеотомии первой плюсневой кости при лечении вальгусной деформации первого пальца стопы. Травматология и ортопедия России. 2023;29(3):65-72. doi: 10.17816/2311-2905-8427.
3. Ильченко Д.В., Рязанцев М.С., Карданов А.А., Королев А.В. Хирургическое лечение третьей стадии Hallux rigidus, сустав сберегающий подход и отдаленные результаты. Гений ортопедии. 2020;26(2):166-172. doi: 10.18019/1028-4427-2020-26-2-166-172.
4. Neufeld SK, Myerson MS. Complications of surgical treatments for adult flatfoot deformities. Foot Ankle Clin. 2001;6(1):179-191. doi: 10.1016/s1083-7515(03)00075-5.
5. Riedel MD, Parker A, Zheng M, et al. Correlation of Soft Tissue Swelling and Timing to Surgery With Acute Wound Complications for Operatively Treated Ankle and Other Lower Extremity Fractures. Foot Ankle Int. 2019;40(5):526-536. doi: 10.1177/1071100718820352.
6. Lebleu J, Pauwels A, Poilvache H, et al. Severe Postoperative Pain in Total Knee Arthroplasty Patients: Risk Factors, Insights and Implications for Pain Management via a Digital Health Approach. J Clin Med. 2023;12(24):7695. doi: 10.3390/jcm12247695.
7. Mitra S, Carlyle D, Kodumudi G, et al. New Advances in Acute Postoperative Pain Management. Curr Pain Headache Rep. 2018;22(5):35. doi: 10.1007/s11916-018-0690-8.
8. Mayoral Rojals V, Charaja M, De Leon Casasola O, et al. New insights into the pharmacological management of postoperative pain: a narrative review. Cureus. 2022;14(3):e23037. doi: 10.7759/cureus.23037.
9. Сараев А.В., Корнилов Н.Н. Эффективность современных пероральных форм нестероидных противовоспалительных препаратов для обезболивания после тотального эндопротезирования коленного сустава. Травматология и ортопедия России. 2023;29(2):46-56. doi: 10.17816/2311-2905-8006.
10. Vieth MP, Deas DE, Archontia Palaiologou A, et al. Effect of intravenous dexamethasone on postoperative pain and swelling following periodontal flap surgery: A randomized controlled trial of patient-centered outcomes. J Periodontol. 2022;93(2):237-245. doi: 10.1002/JPER.21-0153.
11. Singh A, Pentapati KC, Kodali M, et al. Efficacy of Preemptive Dexamethasone versus Methylprednisolone in the Management of Postoperative Discomfort and Pain after Mandibular Third Molar Surgery: A Systematic Review and Meta-Analysis. ScientificWorldJournal. 2023;2023:7412026. doi: 10.1155/2023/7412026.
12. Jiang Y, Wang Z, Huang D, et al. Periarticular Corticosteroid for Superior Pain Relief after Total Knee Arthroplasty: A Randomized Controlled Trial. J Arthroplasty. 2025:S0883-5403(25)01091-5. doi: 10.1016/j.arth.2025.08.050.
13. Wu C, Luo D, Zhu Y, et al. Efficacy of combining intravenous and topical dexamethasone against postoperative pain and function recovery after total knee arthroplasty: A prospective, double-blind, randomized controlled trial. J Orthop Surg (Hong Kong). 2023;31(2):10225536231189782. doi: 10.1177/10225536231189782.
14. Dissanayake R, Du HN, Robertson IK, et al. Does Dexamethasone Reduce Hospital Readiness for Discharge, Pain, Nausea, and Early Patient Satisfaction in Hip and Knee Arthroplasty? A Randomized, Controlled Trial. J Arthroplasty. 2018;33(11):3429-3436. doi: 10.1016/j.arth.2018.07.013.
15. Yasir M, Goyal A, Sonthalia S. Corticosteroid Adverse Effects. 2023 Jul 3. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025.
16. Jiang W, Xu H, Jiang X, et al. Efficacy of Vitamin C as Glucocorticoid Substitute for Reducing Pain and Inflammation After Total Hip Arthroplasty: A Randomized Controlled Trial. J Bone Joint Surg Am. 2025;107(10):1123-1133. doi: 10.2106/JBJS.24.01080.
17. Dresing K, Fischer AC, Lehmann W, et al. Perioperative and posttraumatic anti-edematous decongestive device-based negative pressure treatment for anti-edematous swelling treatment of the lower extremity - a prospective quality study. Int J Burns Trauma. 2021;11(3):145-155.
18. Whing J, Howard AQ. Swelling of the legs and feet. Surgery (Oxford). 2022;40(7):420-431. doi: 10.1016/j.mpsur.2022.05.017.
19. Кардаш А.М., Черний В.И., Городник Г.А., Островой Е.Л. Лечение отека и набухания L-лизином эсцинатом у пациентов с опухолями головного мозга. Украинский нейрохирургический журнал. 2003(3):37-41.
20. Латышева В.Я., Олизарович М.В. Опыт применения L-лизина эсцината в лечении черепно-мозговой травмы. Рецепт. 2008;(5):71-73.
21. Дюсембеков Е.К., Халимов А.Р., Курмаев И.Т. и др. Опыт применения препарата "L-лизинга эсцинат" у пострадавших с очаговыми ушибами головного мозга. Нейрохирургия и неврология Казахстана. 2010; (4):32-36.
22. Гюсан А.О., Ламкова А.Х. Применение L-лизина эсцината при лечении пострадавших с травмами лор-органов. Folia Otorhinolaryngologiae et Pathologiae Respiratoriae. 2015;21(4):63-69.
23. Ситник А.А., Кандыбо И.В., Корзун О.А. Комплексная реабилитация пациентов при тяжелых травмах конечностей. Экстренная медицина. 2012;2(2):154-161.
Review
For citations:
Weber E.V., Smirnov S.S., Shaylieva Sh.L., Zhogina M.A., Kasimova A.R., Bozhkova S.A. Anti-edematous effect of escin lysinate in patients treated with corrective foot osteotomy. Genij Ortopedii. 2026;32(3):371-379. https://doi.org/10.18019/1028-4427-2026-32-3-371-379
JATS XML





























